Pemphigus vulgaris--still a difficult disease to treat

Int J Dermatol. 2010 Feb;49(2):230-2. doi: 10.1111/j.1365-4632.2009.04192.x.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Antibodies, Monoclonal / administration & dosage*
  • Antibodies, Monoclonal, Murine-Derived
  • Antineoplastic Agents / administration & dosage*
  • Azathioprine / therapeutic use*
  • Drug Therapy, Combination
  • Follow-Up Studies
  • Humans
  • Immunoglobulins, Intravenous / therapeutic use
  • Infusions, Intravenous
  • Male
  • Mycophenolic Acid / analogs & derivatives
  • Mycophenolic Acid / therapeutic use
  • Pemphigus / diagnosis
  • Pemphigus / drug therapy*
  • Prednisone / therapeutic use
  • Retreatment
  • Risk Assessment
  • Rituximab
  • Severity of Illness Index
  • Treatment Outcome

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Murine-Derived
  • Antineoplastic Agents
  • Immunoglobulins, Intravenous
  • Rituximab
  • Mycophenolic Acid
  • Azathioprine
  • Prednisone